1 October we become SureStone CapitalSame team, same ABN. Our website and email addresses move to surestone.com.au.

Company Interview / Stock of the day: Neuren Pharmaceuticals (NEU)

Loading

Preparing video

Stock of the day: Neuren Pharmaceuticals (NEU)

Company Interview05 Aug, 2026

Buy, Hold, or Sell? Get the verdict on Neuren Pharmaceuticals (NEU) with our experts, Andrew Wielandt from DP Wealth Advisory and Henry Jennings from Marcus Today

Copyright © 2026 Ausbiz Capital